Prohost Biotech
Prohost Biotech
Send Message
Prohost Biotech
Stop FollowingProhost Biotech
ABOUT
The enormous advancement in the biological sciences that is taking place has begun to change the traditional way of practicing medicine. Far-reaching biological products are being approved and news about breakthroughs are occupying the headlines. However, selecting the biotechnology firms in which to invest requires not only an understanding of the company's finances, but also a knowledge of the company's potential and the potential and scientific validity of it's products and technologies.Our MissionProhost evaluates biotechnology companies, their products and technologies, their scientists and managers, as well as their finances. Our goal is to impart our readers with the knowledge and insight so that they may have a ...More
heightened understanding and appreciation for the biotechnology industry. We hope this newfound insight can help our readers identify the newest blockbuster technologies and discover the next industry leaders.Company ProfileProhost is the premier biotechnology newsletter. In printed form, The Prohost Biotechnology Newsletter has been in circulation since 1992. Our readers are comprised of fund managers, investors, medical professionals and all kinds of individuals with one common interest, biotechnology.Prohost publishes a monthly Newsletter. The Newsletter is posted on the web in the Members' Area.Prohost is ranked
SNAPSHOT
- Description: Newsletter author. Trading frequency: Not Trading
- Interests: Stocks - long, Tech stocks
COMPANY
Prohost Biotech The enormous advancement in the biological sciences that is taking place has begun to change the traditional way of practicing medicine. Far-reaching biological products are being approved and news about breakthroughs are occupying the headlines. However, selecting the biotechnology firms in which to invest ...More
requires not only an understanding of the company's finances, but also a knowledge of the company's potential and the potential and scientific validity of it's products and technologies.
Our Mission:
Prohost evaluates biotechnology companies, their products and technologies, their scientists and managers, as well as their finances. Our goal is to impart our readers with the knowledge and insight so that they may have a heightened understanding and appreciation for the biotechnology industry. We hope the insight we provide would help our readers identify the newest technologies, the real blockbuster drugs and discover the next industry leaders.
Company Profile:
Prohost is the premier biotechnology E- Newsletters. The Prohost Biotechnology Newsletters have been in circulation since 1992. Our readers are comprised of fund managers, investors, medical professionals and all kinds of individuals with one common interest, biotechnology.
Prohost posts various news and comments, in addition to Newsletters that sum them all. All the messages are posted on the web in the Members' Area.
Prohost was ranked #1 from among 355 publications by an independent accounting firm hired by Select Information Exchange (SIE). Prohost Newsletters were rated based on their performances over the two year period of 1999 and 2000.
BLOG
Currently, there are no blog details for Prohost Biotech.
Book
Currently, there are no book details for Prohost Biotech.
Latest Comments
more »
- "I like to purchase a ... on Gilead In The Fight Against Cancer
- We have tendency to agree w... on Does This Hot Biotech Still Have Legs Or Is It ...
- A great firm. A very convin... on Array BioPharma's CEO Discusses F2Q2013 (Qtr En...
- Tinsley09 the link of this ... on Northwest Biotherapeutics: An Example Of Reform...
- Dear: we are still in the b... on Amgen's Prolia: Breakthrough Blockbuster
Latest comments on Prohost's Articles
- a789877 on Why The Amgen And Cytokinetics Agreement Is Goo...
- tickup on Why The Amgen And Cytokinetics Agreement Is Goo...
- pagreen1966 on Why The Amgen And Cytokinetics Agreement Is Goo...
- Michael Webb on Why The Amgen And Cytokinetics Agreement Is Goo...
- petethepanzer on Agenus Continues to Outperform
LATEST ARTICLES & INSTAPOSTS
more »

